semaglutide renal impairment dosing (Ozempic) for Type 2 Diabetes Mellitus Semaglutide isn’t just a “weight-loss

Reasons where microdosing Ozempic may be appropriate include: 1) Tapering off from standard treatment dosages- Microdose Ozempic as maintenance treatment This is probably the most common reason why a patient would microdose Ozempic- to maintain the results from Ozempic treatment after coming off a ~6-12 month treatment course

In a randomised controlled trial with over 1800 participants comparing tirzepatide to semaglutide, the tirzepatide group reported more serious adverse events (5-7% VS 3%) and higher discontinuation rates due to adverse events (6-8.5% VS 4%)

Phen-Fen also evoked modest weight loss but caused the deaths of hundreds of people, with exact numbers still unknown

While its currently FDA-approved for type 2 diabetes under the brand name Mounjaro, many providers now prescribe it off-label for weight loss due to its strong outcomes in early studies

A good visit should feel like a talk, not a sales pitch

Nauck and colleagues (1993) showed that GLP-1 infusion normalized elevated fasting glucose levels in T2D patients (via enhanced insulin secretion)